Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Cigna Global offers health services and benefits to Canadian expatriates

Cigna Global Health Benefits has announced that it is offering its medical, dental, vision and pharmacy benefits to Canadian expatriates and their eligible family members through its CignaLinks network.

Published By MarketLine
27 Mar 2015
NewsWire
NewsWire

Illumina files NIPT patent infringement suit against Premaitha

Illumina, Inc., a provider of sequencing and array-based technologies, and its wholly-owned subsidiary, Verinata Health Inc., have filed a patent infringement suit against Premaitha Health plc for non-invasive prenatal testing, or NIPT, patents in the High Court of Justice, Chancery Division, Patents Court in the UK.

Published By MarketLine
27 Mar 2015
NewsWire
NewsWire

Quidel receives FDA clearance for trichomoniasis diagnostic assay

Quidel Corporation, a provider of rapid diagnostic testing solutions, has received clearance from the FDA to market its AmpliVue Trichomonas Assay for the detection of nucleic acids isolated from clinician-collected vaginal swab specimens obtained from symptomatic or asymptomatic female patients.

Published By MarketLine
27 Mar 2015
NewsWire
NewsWire

Thermo Fisher Scientific releases CE-IVD Fusion Transcript kit

Thermo Fisher Scientific has announced the release of the CE-IVD Oncomine Solid Tumour Fusion Transcript kit for next-generation sequencing.

Published By MarketLine
27 Mar 2015
NewsWire
NewsWire

Emergent BioSolutions develops MVA EBOZ vaccine candidate

Emergent BioSolutions Inc. has announced that under agreements signed with the University of Oxford, GSK, and the National Institutes of Health's National Institute of Allergy and Infectious Diseases, or NIAID, it has manufactured a modified vaccinia Ankara, or MVA, Ebola Zaire vaccine candidate, or MVA EBOZ, anticipated for use in a Phase I clinical study.

Published By MarketLine
27 Mar 2015
NewsWire
NewsWire

BioInvent to initiate Phase I/IIa medulloblastoma drug development program

BioInvent International AB, a research-based pharmaceutical company, has announced plans to initiate Phase I/IIa program with TB-403 in medulloblastoma patients during the second half of 2015.

Published By MarketLine
27 Mar 2015
NewsWire
NewsWire

Cerner and Intermountain implement iCentra electronic health record system

Cerner Corp., a healthcare IT company, and Intermountain Healthcare, a not-for-profit system, have announced the implementation of iCentra, a model electronic health record, or EHR, practice management and revenue cycle system, at two Intermountain hospitals and 24 clinics across northern Utah.

Published By MarketLine
27 Mar 2015
NewsWire
NewsWire

Cerus enrolls first patient in platelet system study

Cerus Corporation, a biomedical products company, has enrolled the first patient in its TReatment UsE, or TRUE, study to make the INTERCEPT Blood System for platelets available to regions in the US with outbreaks of chikungunya and dengue virus under an expanded access investigational device exemption, or IDE.

Published By MarketLine
27 Mar 2015
NewsWire
NewsWire

3M files patent infringement lawsuit against Danville Materials

The 3M Company and 3M Innovative Properties Co. have filed a patent infringement lawsuit in federal district court in Minnesota against Danville Materials Inc., a manufacturer of dental products for clinical dentists.

Published By MarketLine
27 Mar 2015
NewsWire
NewsWire

InSite Vision settles patent infringement lawsuit with Mylan

InSite Vision Incorporated, an ophthalmic product development company, has announced that it, along with other plaintiffs, has entered into a settlement agreement to dismiss a patent infringement lawsuit against Mylan Pharmaceutical, Inc.

Published By MarketLine
27 Mar 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.